20/20 GeneSystems, Inc. (Equity)
Funding Details
Awarder
StartEngine
Date Award
June 13, 2024
Vertical
Digital Diagnostics
Funding URL
View Funding Page
Premoney Valuation
$1,000,000
Valuation
$57,380,000
Funding Amount
$1,000,000
Company Info
Traction
The company has seen significant revenue growth, with over 300% year-over-year increase. They have partnerships with China’s Ping An Ventures, a major Healthcare AI company, and thousands of investors.
Revenue Amount
$30,000,000
Organizations Involved
China’s Ping An Ventures, thousands of investors
Market
Healthcare
Location
Wilmington, DE, US
Coinvestors
China’s Ping An Ventures, thousands of investors
Company Description

20/20 GeneSystems is a digital diagnostics company focused on reducing cancer mortality through early detection. They have expanded their test menu to include Covid-19 testing solutions. The company leverages real-world data and machine learning to improve the accuracy of clinical lab testing, with plans to expand to heart disease and other chronic conditions.

Links
Website
Back to HomeBack to Digital Diagnostics DealsView Funding Announcement